1. AB0746 Apremilast, an Oral Phosphodiesterase 4 Inhibitor, and the Impact of Baseline Weight and BMI on ACR20 and HAQ-DI Response: Pooled Results from 3 Phase 3, Randomized, Controlled Trials. (10th June 2014) Authors: Schett, G.; Mease, P.; Gladman, D.; Kavanaugh, A.; Adebajo, A.; Gomez-Reino, J.; Wollenhaupt, J.; Cutolo, M.; Lespessailles, E.; Hu, C.; Stevens, R.; Edwards, C.; Birbara, C. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0757 Achievement of A Combined Clinical and Radiographic Endpoint in Patients with Psoriatic Arthritis in the ADEPT Trial. (10th June 2014) Authors: Mease, P.; Karunaratne, P.M.; Kupper, H.; Hojnik, M.; Dorr, A.P.; McInnes, I. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1054 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0758 Change in Weight from Baseline during the Palace Clinical Trial Program with Apremilast, an Oral Phosphodiesterase 4 Inhibitor: Pooled Results from 3 Phase 3, Randomized, Controlled Trials. (10th June 2014) Authors: Mease, P.; Gladman, D.; Kavanaugh, A.; Adebajo, A.; Gomez-Reino, J.; Wollenhaupt, J.; Schett, G.; Shah, K.; Hu, C.; Stevens, R.; Edwards, C.; Birbara, C. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1055 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0822 Therapeutic Response in Adalimumab-Treated Patients with Psoriatic Arthritis in Relation to Weight. (9th June 2015) Authors: Mease, P.; Gladman, D.D.; Ritchlin, C.T.; Warren, R.B.; Rubant, S.; Li, Y.; Dorr, A.P.; Anderson, J.K. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB1158 Quality of Life in Patients with Active Peripheral SPA is Similarly Impaired as in Other Rheumatic Diseases and Influenced by Disease Activity But not Disease Duration. (9th June 2015) Authors: Mease, P.; van der Heijde, D.; Mittal, M.; Joshi, A.; Xu, Y.; Pangan, A.; Song, I.-H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1290 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0128 Utility of Enthesitis Assessments in Peripheral Spondyloarthritis – Data from the Ability-2 Trial. (10th June 2014) Authors: Mease, P.; Van den Bosch, F.; Baeten, D.L.; Sieper, J.; Song, I.-H.; Karunaratne, P.M.; Pangan, A.L. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0138 A Psychometric Analysis of Outcome Measures in Trials of Peripheral Spondyloarthritis. (10th June 2014) Authors: Ramiro, S.; Turina, M.; Baeten, D.L.; Mease, P.; Paramarta, J.E.; Song, I.-H.; Pangan, A.L.; Landewe, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0201 Analysis of infection risk in patients with limited return of peripheral B cells after a period of 2 years or more following any rituximab treatment course in RA clinical trials. (23rd January 2014) Authors: Mease, P.; van Vollenhoven, R.; Durez, P.; Sheeran, T.; Dougados, M.; Gόmez-Reino, J.J.; Tyson, N.; Mehbob, A.; Lehane, P.B. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0425 Similar levels of disease activity in patients with oligoarticular vs. polyarticular peripheral spondyloarthritis. (23rd January 2014) Authors: Van den Bosch, F.; Mease, P.; van der Heijde, D.; Rudwaleit, M.; Pangan, A. L. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0448 Secukinumab Provides Sustained Improvements in The Signs and Symptoms of Active Psoriatic Arthritis: 2-Year Efficacy and Safety Results from The Phase 3 Randomised, Double-Blind, Placebo-Controlled Trial, Future 1. (15th July 2016) Authors: Kavanaugh, A.; Mease, P.; Reimold, A.; Tahir, H.; Rech, J.; Hall, S.; Geusens, P.; Wang, Z.; Mpofu, S. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 598 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗